Canntab Therapeutics Limited
Canntab Therapeutics Limited
Canntab Therapeutics Limited is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. Canntab has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use. Simply put, Canntab's mission is to put the "Medical" into medicinal cannabis.
Canntab Therapeutics Limited (PILL)
Company Info
SEDAR Information
Company Info
Capitalization
News Releases
CANNTAB ANNOUNCES CORPORATE UPDATE
Bulletins
2024-0613 - Delist - Canntab Therapeutics Limited (PILL)
le 14 juin/June 2024
The common shares of Canntab Therapeutics Limited will be delisted from the CSE at market close today, June 14, 2024.
Canntab Therapeutics is currently suspended. See bulletin 2023-1008.
___________________________